EGFR and cancer: Using this approach in combination with SPT, MET-EGFR heteromers were demonstrated for the first time and the promotion of these complexes following ligand activation in cancer cell lines was monitored, giving both high-resolution static and dynamic information about these complexes (Harwardt et al, 2020).